Ghedini, Pietro*; Bossert, I.; Zanoni, L.; Ceci, F.; Graziani, T.; Castellucci, P.; Ambrosini, V.; Massari, F.; Nobili, E.; Melotti, B.; Musto, A.; Zoboli, S.; Antunovic, L.; Kirienko, M.; Chiti, A.; Mosconi, C.; Ardizzoni, A.; Golfieri, R.; Fanti, S.; Nanni, C., Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2018, 45, pp. 751 - 758 [Scientific article]
Cheng L.; Lopez-Beltran A.; Massari F.; Maclennan G.T.; Montironi R., Molecular testing for BRAF mutations to inform melanoma treatment decisions: A move toward precision medicine, «MODERN PATHOLOGY», 2018, 31, pp. 24 - 38 [Scientific article]
Cimadamore A.; Cheng M.; Santoni M.; Lopez-Beltran A.; Battelli N.; Massari F.; Galosi A.B.; Scarpelli M.; Montironi R., New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen, «FRONTIERS IN ONCOLOGY», 2018, 8, Article number: 653 , pp. 1 - 11 [Scientific article]Open Access
Bimbatti D.; Ciccarese C.; Fantinel E.; Sava T.; Massari F.; Bisogno I.; Romano M.; Porcaro A.; Brunelli M.; Martignoni G.; Mazzarotto R.; Artibani W.; Tortora G.; Iacovelli R., Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma, «UROLOGIC ONCOLOGY», 2018, 36, pp. 526 - 531 [Scientific article]
Montironi R.; Cimadamore A.; Gasparrini S.; Mazzucchelli R.; Santoni M.; Massari F.; Cheng L.; Lopez-Beltran A.; Scarpelli M., Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma, «EXPERT REVIEW OF ANTICANCER THERAPY», 2018, 18, pp. 685 - 693 [Scientific article]
Massari F.; Santoni M.; Di Nunno V.; Cimadamore A.; Battelli N.; Scarpelli M.; Cheng M.; Lopez-Beltran A.; Cheng L.; Montironi R., Quick steps toward precision medicine in renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2018, 3, pp. 283 - 285 [Scientific article]
Di Nunno V.; Santoni M.; Cimadamore A.; Battelli N.; Massari F., Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step?, «EUROPEAN UROLOGY», 2018, 74, pp. 118 - 119 [Scientific article]
Massari F.; Di Nunno V., Re: Jose Luis Perez-Gracia, Yohann Loriot, Jonathan E. Rosenberg, et al. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens. Eur Urol 2018;73:462–8, «EUROPEAN UROLOGY», 2018, 74, pp. 12 - 13 [Scientific article]
Di Nunno V.; Santoni M.; Massari F., Re: Michael B. Atkins, Elizabeth R. Plimack, Igor Puzanov, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-randomised, Open-label, Dose-finding, and Dose-expansion Phase 1b Trial. Lancet Oncol 2018;19:405–15, «EUROPEAN UROLOGY», 2018, 74, pp. 50 - 50 [Scientific article]
Massari F.; Di Nunno V.; Ardizzoni A., Re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62–8, «EUROPEAN UROLOGY», 2018, 73, pp. 72 - 72 [Scientific article]
Di Nunno V.; Gatto L.; Santoni M.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Scarpelli M.; Montironi R.; Massari F., Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer, «FRONTIERS IN ONCOLOGY», 2018, 8, Article number: 397 , pp. 1 - 9 [Scientific article]Open Access
Mosillo, Claudia; Ciccarese, Chiara; Bimbatti, Davide; Fantinel, Emanuela; Volta, Alberto Dalla; Bisogno, Iolanda; Zampiva, Ilaria; Santoni, Matteo; Massari, Francesco; Brunelli, Matteo; Montironi, Rodolfo; Tortora, Giampaolo; Iacovelli, Roberto, Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research, «CANCER TREATMENT REVIEWS», 2018, 67, pp. 29 - 33 [Scientific article]
Procopio G.; Prisciandaro M.; Iacovelli R.; Cortesi E.; Fornarini G.; Facchini G.; Carteni G.; Sabbatini R.; Del Bene G.; Galli L.; Caserta C.; Multari A.G.; Bregni M.; Massari F.; Buti S.; De Giorgi U.; Zustovich F.; Milella M.; Calabro F.; Mancini M.L.; Tortora G.; Vernieri C.; Santini D.; Soraru M.; Ricotta R.; Masini C.; Tucci M.; Fedeli S.L.; Ortega C.; Mecozzi A.; Ratta R.; Sternberg C.N.; Verzoni E., Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program, «CLINICAL GENITOURINARY CANCER», 2018, 16, pp. 945 - 951 [Scientific article]
Massari F, Di Nunno V, Gatto L, Santoni M, Schiavina R, Cosmai L, Brunocilla E, Ardizzoni A, Porta C, Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy., «TARGETED ONCOLOGY», 2018, 13, pp. 705 - 714 [Scientific article]
Lopez-Beltran A.; Henriques V.; Cimadamore A.; Santoni M.; Cheng L.; Gevaert T.; Blanca A.; Massari F.; Scarpelli M.; Montironi R., The identification of immunological biomarkers in kidney cancers, «FRONTIERS IN ONCOLOGY», 2018, 8, Article number: 456 , pp. 1 - 13 [Scientific article]Open Access
